Hormone Replacement Therapy (HRT) could assistance forestall Alzheimer's Dementia among women astatine hazard of processing the illness - according to University of East Anglia research.
The survey shows that HRT usage is associated with amended memory, cognition and larger encephalon volumes successful aboriginal beingness among women carrying the APOE4 cistron - the strongest hazard origin cistron for Alzheimer's disease.
The probe squad recovered that HRT was astir effectual erstwhile introduced aboriginal successful the menopause travel during perimenopause.
Prof Anne-Marie Minihane, from UEA's Norwich Medical School and manager of the Norwich Institute for Healthy Aging astatine UEA, led the survey successful collaboration with Prof Craig Ritchie astatine the University of Edinburgh.
Prof Minihane said: "We cognize that 25 per cent of women successful the UK are carriers of the APOE4 cistron and that astir 2 thirds of Alzheimer's patients are women.
"In summation to surviving longer, the crushed down the higher pistillate prevalence is thought to beryllium related to the effects of menopause and the interaction of the APOE4 familial hazard origin being greater successful women.
"We wanted to find retired whether HRT could forestall cognitive diminution successful at-risk APOE4 carriers."
The probe squad studied information from 1,178 women participating successful the European Prevention of Alzheimer's Dementia inaugural - which was acceptable up to survey participants' encephalon wellness implicit time.
The task spanned 10 countries and tracked participants' brains from 'healthy' to a diagnosis of dementia successful some. Participants were included if they were implicit 50 and dementia-free.
The probe squad studied their results to analyse the interaction of HRT connected women carrying the APOE4 genotype.
Dr Rasha Saleh, besides from UEA's Norwich Medical School, said: "We recovered that HRT usage is associated with amended representation and larger encephalon volumes among at-risk APOE4 cistron carriers. The associations were peculiarly evident erstwhile HRT was introduced aboriginal - during the modulation to menopause, known arsenic perimenopause.
"This is truly important due to the fact that determination person been precise constricted cause options for Alzheimer's illness for 20 years and determination is an urgent request for caller treatments.
"The effects of HRT successful this reflection study, if confirmed successful an involution trial, would equate to a encephalon property that is respective years younger."
Prof Minihane said: "Our probe looked astatine associations with cognition and encephalon volumes utilizing MRI scans. We did not look astatine dementia cases, but cognitive show and little encephalon volumes are predictive of aboriginal dementia risk.
Prof Michael Hornberger, from UEA's Norwich Medical School, said: : "It's excessively aboriginal to accidental for definite that HRT reduces dementia hazard successful women, but our results item the imaginable value of HRT and personalised medicine successful reducing Alzheimer's risk.
"The adjacent signifier of this probe volition beryllium to transportation retired an involution proceedings to corroborate the interaction of starting HRT aboriginal connected cognition and encephalon health. It volition besides beryllium important to analyse which types of HRT are astir beneficial," helium added.
Prof Craig Ritchie, from the University of Edinburgh, said: "This important uncovering from the EPAD Cohort highlights the request to situation galore assumptions astir aboriginal Alzheimer's illness and its treatment, particularly erstwhile considering women's encephalon health. An effect connected some cognition and encephalon changes connected MRI supports the conception that HRT has tangible benefit. These archetypal findings request replication nevertheless successful different populations."
'Hormone Replacement Therapy is associated with improved cognition and larger encephalon volumes successful astatine hazard APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort' is published successful the diary Alzheimer's Research and Therapy.